| Pro‐apoptotic function of HBV X protein is mediated by interaction with c‐FLIP and enhancement of death‐inducing signal KH Kim, BL Seong The EMBO Journal, 2003 | 203 | 2003 |
| Hepatitis B virus e antigen variants S Tong, KH Kim, C Chante, J Wands, J Li International journal of medical sciences 2 (1), 2, 2005 | 166 | 2005 |
| Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients ES Park, AR Lee, DH Kim, JH Lee, JJ Yoo, SH Ahn, H Sim, S Park, ... Journal of Hepatology 70 (6), 1093-1102, 2019 | 130 | 2019 |
| Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene N Khan, M Guarnieri, SH Ahn, J Li, Y Zhou, G Bang, KH Kim, JR Wands, ... Journal of virology 78 (7), 3262-3270, 2004 | 101 | 2004 |
| Pharmacophore-based virtual screening: a review of recent applications KH Kim, ND Kim, BL Seong Expert opinion on drug discovery 5 (3), 205-222, 2010 | 91 | 2010 |
| Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme K Ito, KH Kim, ASF Lok, S Tong Journal of virology 83 (8), 3507-3517, 2009 | 89 | 2009 |
| Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin DY Kim, KH Kim, ND Kim, KY Lee, CK Han, JH Yoon, SK Moon, SS Lee, ... Journal of medicinal chemistry 49 (19), 5664-5670, 2006 | 86 | 2006 |
| Peptide amidation: Production of peptide hormonesin vivo andin vitro KH Kim, BL Seong Biotechnology and Bioprocess Engineering 6, 244-251, 2001 | 85 | 2001 |
| Discovery and development of anti-HBV agents and their resistance KH Kim, ND Kim, BL Seong Molecules 15 (9), 5878-5908, 2010 | 81 | 2010 |
| A new combination MALDI matrix for small molecule analysis: application to imaging mass spectrometry for drugs and metabolites SR Shanta, TY Kim, JH Hong, JH Lee, CY Shin, KH Kim, YH Kim, SK Kim, ... Analyst 137 (24), 5757-5762, 2012 | 79 | 2012 |
| Global changes in phospholipids identified by MALDI MS in rats with focal cerebral ischemia [S] SR Shanta, CS Choi, JH Lee, CY Shin, YJ Kim, KH Kim, KP Kim Journal of lipid research 53 (9), 1823-1831, 2012 | 71 | 2012 |
| Protein solubility and folding enhancement by interaction with RNA SI Choi, KS Han, CW Kim, KS Ryu, BH Kim, KH Kim, SI Kim, TH Kang, ... PloS one 3 (7), e2677, 2008 | 70 | 2008 |
| Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5′-UTR of TRIM22 KH Lim, ES Park, DH Kim, KC Cho, KP Kim, YK Park, SH Ahn, SH Park, ... Gut 67 (1), 166-178, 2018 | 65 | 2018 |
| Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion G Bang, KH Kim, M Guarnieri, F Zoulim, S Kawai, J Li, J Wands, S Tong Virology 332 (1), 216-224, 2005 | 65 | 2005 |
| Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression M Guarnieri, KH Kim, G Bang, J Li, Y Zhou, X Tang, J Wands, S Tong Journal of virology 80 (2), 587-595, 2006 | 62 | 2006 |
| Roles of hepatocyte nuclear factors in hepatitis B virus infection DH Kim, HS Kang, KH Kim World Journal of Gastroenterology 22 (31), 7017, 2016 | 61 | 2016 |
| RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function KH Lim, KH Kim, SI Choi, ES Park, SH Park, K Ryu, YK Park, SY Kwon, ... PloS one 6 (8), e22258, 2011 | 61 | 2011 |
| Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir WH Choe, SP Hong, BK Kim, SY Ko, YK Jung, JH Kim, JE Yeon, KS Byun, ... Antiviral therapy 14 (7), 985-993, 2009 | 60 | 2009 |
| Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response. KKH Shin GC, Kang HS, Lee AR Autophagy. 12 (12), 2451-2466., 2016 | 58 | 2016 |
| Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents ND Kim, ES Park, YH Kim, SK Moon, SS Lee, SK Ahn, DY Yu, KT No, ... Bioorganic & medicinal chemistry 18 (19), 7092-7100, 2010 | 58 | 2010 |
Kwang Pyo KimDepartment of Applied Chemistry, Kyung Hee UniversityPotvrđena adresa e-pošte na khu.ac.kr
